Kolexia
Bloch Vanessa
Pharmacien
Hôpital Lariboisière
Paris, France
96 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Troubles liés à la cocaïne Troubles liés à une substance Alcoolisme Troubles liés aux opiacés Dépendance à l'héroïne Syndrome de sevrage Psychoses toxiques Abus de marijuana Intoxication

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Corrigendum to "Valproate, divalproex, valpromide: Are the differences in indications justified?" Biomed. Pharmacother., 158 (2023) 114051.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie   12 octobre 2023
Factors associated with lamotrigine concentration/dose ratio in individuals with bipolar disorders
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology   01 août 2023
Behavioral sensitization to psychostimulants and opioids: What is known in rodents and what still needs to be explored in humans?
Progress in neuro-psychopharmacology & biological psychiatry   20 juillet 2023
Lamotrigine in mood disorders: Flash survey on prescribing habits and blood tests practices.
L'Encephale   26 mai 2023
Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs.
Pharmaceutics   18 mars 2023
Prevalence of benzodiazepine use disorder during hospitalization for alcohol detoxification.
Fundamental & clinical pharmacology   15 mars 2023
Valproate, divalproex, valpromide: Are the differences in indications justified?
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie   13 décembre 2022
A specific cognitive behavioral group therapy program for stimulant use disorder.
Frontiers in psychiatry   30 novembre 2022
Cytochromes P450 and P-Glycoprotein Phenotypic Assessment to Optimize Psychotropic Pharmacotherapy: A Retrospective Analysis of Four Years of Practice in Psychiatry.
Journal of personalized medicine   08 novembre 2022
Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal-associated brain damage: A pilot study.
Addiction biology   31 octobre 2022